Galapagos NV Cash Conversion Cycle 2011-2026 | GLPG

Annual Cash Conversion Cycle Galapagos NV

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	67.1	-25.1	-173	-76.8	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
67.1	-173	-51.8

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	3.11 K	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	-3.12 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Coherus BioSciences CHRS	149	$ 1.73	5.18 %	$ 203 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Celldex Therapeutics CLDX	-3.74 K	$ 31.65	2.59 %	$ 2.1 B	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
AstraZeneca PLC AZN	-58	-	-	$ 96.9 B	Britain
CRISPR Therapeutics AG CRSP	1.1 K	$ 53.52	3.74 %	$ 4.81 B	Schweiz
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Compugen Ltd. CGEN	-82.7	$ 2.68	1.13 %	$ 250 M	Israel
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Enlivex Therapeutics Ltd. ENLV	-981	$ 0.78	14.04 %	$ 35.6 M	Israel
Esperion Therapeutics ESPR	99.7	$ 3.13	0.32 %	$ 651 M	USA
Eton Pharmaceuticals ETON	115	$ 31.66	1.18 %	$ 852 M	USA
Affimed N.V. AFMD	31.4	-	-34.95 %	$ 21.5 M	Germany
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Celyad Oncology SA CYAD	-55.7 K	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	214	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Grifols, S.A. GRFS	0.000171	$ 8.08	0.9 %	$ 5.49 B	Spain
Hutchison China MediTech Limited HCM	95.8	$ 11.72	-0.26 %	$ 10.1 B	China
Cyclacel Pharmaceuticals CYCCP	-1.6 K	-	-4.36 %	$ 27 M	USA
Heron Therapeutics HRTX	751	$ 0.9	2.13 %	$ 150 M	USA
Anika Therapeutics ANIK	192	$ 14.76	-0.87 %	$ 212 M	USA
Advaxis ADXS	-82.3 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA